Adults at high risk for HIV infection have low rates of vaccination against HPV
ATLANTA -- Adults who are at high risk of becoming infected with the human immunodeficiency virus (HIV), which causes AIDS, ...
ATLANTA -- Adults who are at high risk of becoming infected with the human immunodeficiency virus (HIV), which causes AIDS, ...
Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced it was ...
ATLANTA -- A common single nucleotide polymorphism (SNP) was associated with increased risk for developing stroke in childhood survivors who ...
ATLANTA -- Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with ...
ATLANTA -- Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the ...
ATLANTA -- Surgery was associated with higher survival rates for patients with HER2-positive (HER2+) stage 4 breast cancer compared with ...
Data presented in a news conference at AACR Annual Meeting ATLANTA - Switching pancreatic cancer patients to the PARP inhibitor ...
NIH experts review puzzling muscle paralysis condition in childrenCredit: CDC/Cynthia S. Goldsmith, Yiting Zhang WHAT: Acute flaccid myelitis (AFM) presents ...
Credit: Sanford Burnham Prebys LA JOLLA, CALIF. - April 2, 2019 - The advent of immune checkpoint inhibitors--which "release the ...
ESMO Breast Cancer Congress, May 2-4, 2019, Berlin, GermanyCredit: © European Society for Medical Oncology Lugano, Switzerland, 2 April 2019 ...
Credit: Matthew Brown BINGHAMTON, N.Y. - Researchers at Binghamton University, State University of New York, have developed skin-inspired electronics to ...
Four FDA-approved tablets available for battling allergies ARLINGTON HEIGHTS, IL - (APRIL 2, 2019) - Allergy shots (subcutaneous immunotherapy or ...
The partnership reflects the expanding synergism of Indo-Israel medical collaborationCredit: Ocular Discovery New Delhi, India - April 2, 2019 - ...
Dolutegravir may reduce deaths in women, HIV transmission to children and men Although a woman's use of the HIV drug ...
When it comes to health care proposals, 'everything old is new again' As political leaders debate the future of the ...
Share of Medicare Advantage plans with broad networks increased from 80.1 percent in 2011 to 82.5 percent in 2015, and ...
Credit: Caltech Devising the best treatment for a patient with cancer requires doctors to know something about the traits of ...
ATLANTA -- The investigational anticancer therapeutic LOXO-195 (now known as BAY 2731954), which targets a family of proteins called TRKs, ...
Investigators at the Medical University of South Carolina report in Microbiome that autoantibody production in HIV-positive patients who have undergone ...
University of Minnesota researchers conducted the largest study of childhood cancer after conception by IVF to date In the past ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.